Your browser doesn't support javascript.
loading
Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer.
Modi, N D; Danell, N O; Perry, R N A; Abuhelwa, A Y; Rathod, A; Badaoui, S; McKinnon, R A; Haseloff, M; Shahnam, A; Swain, S M; Welslau, M; Sorich, M J; Hopkins, A M.
Affiliation
  • Modi ND; College of Medicine and Public Health, Flinders University, South Australia.
  • Danell NO; College of Medicine and Public Health, Flinders University, South Australia.
  • Perry RNA; College of Medicine and Public Health, Flinders University, South Australia.
  • Abuhelwa AY; College of Medicine and Public Health, Flinders University, South Australia.
  • Rathod A; College of Medicine and Public Health, Flinders University, South Australia.
  • Badaoui S; College of Medicine and Public Health, Flinders University, South Australia.
  • McKinnon RA; College of Medicine and Public Health, Flinders University, South Australia.
  • Haseloff M; College of Medicine and Public Health, Flinders University, South Australia.
  • Shahnam A; Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia.
  • Swain SM; University of Georgetown Medical Center, Washington DC, USA.
  • Welslau M; Onkologie Aschaffenburg, Aschaffenburg, Germany.
  • Sorich MJ; College of Medicine and Public Health, Flinders University, South Australia.
  • Hopkins AM; College of Medicine and Public Health, Flinders University, South Australia. Electronic address: ashley.hopkins@flinders.edu.au.
ESMO Open ; 7(3): 100475, 2022 06.
Article in En | MEDLINE | ID: mdl-35490579

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication: